Michael T. Osterholm: the future of ADVOCACY on AMR

  13 January 2021

In this first article, Dr Michael T. Osterholm, director of the Center for Infectious Disease Research and Policy (CIDRAP) at the University of Minnesota and, most recently, a member of President-elect Joe Biden’s Transition COVID-19 Advisory Board, describes how we can all become advocates for a new and better future, in spite of the increasingly complex threat of antimicrobial resistance.

 

Further reading: BSAC
Author(s): Michael Osterholm
Effective Surveillance  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

Evotec

JSS University





Technology Database

Display your AMR Technology, Product and Service

Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.

Read more and make your own Technology Page >>
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!